Patents Assigned to BLACKSMITH MEDICINES, INC.
  • LpxC inhibitor and methods of making
    Patent number: 11731962
    Abstract: Provided herein is an LpxC inhibitor compound, as well as methods of making and pharmaceutical compositions comprising said compound, and methods of use thereof in the treatment of disease that would benefit from treatment with an LpxC inhibitor, including gram-negative bacterial infections such as urinary tract infections and the like.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: August 22, 2023
    Assignee: BLACKSMITH MEDICINES, INC.
    Inventors: Min Teng, Baskar Nammalwar, David T. Puerta